Atea Pharmaceuticals, Inc.

US$4.31As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AVIRHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (27.69%)
Div yield —
ROE (58.14%)
Biotechnology
Beta (5Y) 0.72
PE TTM —
TSR TTM 32.62%
Mkt cap US$345.7M
ROIC (40.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.66
8.22%
(97.98%)
Hold 4|10|11|6|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.13
0.13
0.13
40.22%
39.31%
32.14%
28.89%
Revenue$M
15.91
15.64
15.38
15.03
1.27%
(4.83%)
(4.60%)
(4.43%)
Peers (US$345.7M)
Cap (US$)
PE
344.6M
—
Capital
TTM
5Y
10Y
Leveragex
1.586
0.088
0.077
EBIT/Intx
1.219
0.055
0.058
Own earn%
(61.72)
30.31
33.25
Sh yield%
35.05
7.74
6.71
Owners
Insiders/Inst%
12.38
70.19
Short interest%
5.50
SBC / revenue%
5.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
4–10
$1 testx
0.1
Incr. ROIC%
4